cosmetic pigment production Debut Biotechnology DIC partnership – CosmeticsDesign.com USA
“With our advanced cell-free biomanufacturing platform, we’re able to produce color ingredients that are simply not possible with traditional fermentation-based biomanufacturing,” explains Joshua Britton, CEO of Debut Biotechnology, in a recent media release about...
Opinion: Biotechnology Greed Is Prolonging the Pandemic. It’s Inexcusable. – Undark Magazine
Did greed just save the day? That’s what British Prime Minister Boris Johnson claimed recently. “The reason we have the vaccine success,” he said in a private call to Conservative members of Parliament,...
Amazon invested millions in a pre-revenue company with a system for measuring human proteins...
Andy Jassy, CEO of Amazon and then CEO of Amazon Web Services, listens during the Amazon Web Services Summit in San Francisco on April 19, 2017.David Paul Morris | Bloomberg | Getty ImagesAmazon invested...
Bacteriophages named after Norfolk village of Colney could help combat C. difficile infections
Viruses have a menacing reputation for causing disease but some that target bacteria could actually benefit human health. These are called bacteriophages, and a group of them named after the Norfolk village of Colney...
Study offers genetic insights into the underlying biology of reproductive aging
The age at which women go through menopause is critical for fertility and impacts healthy aging in women, but reproductive aging has been difficult for scientists to study and insights into the underlying biology...
Mapping the Future of Cell Culture and Cell Line Development
If modern cell-based bioprocessing is to improve its ability to churn out biotherapeutics—not just tried-and-true antibodies, but also bi- and trispecific antibodies, as well as viral antigens and other novel vaccines—it will have to...
Exicure, Inc. to Present at the BTIG Virtual Biotechnology Conference – Business Wire
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc.® (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced that CEO David Giljohann will present at the BTIG Virtual...
Open-access database could speed up repurposing of old drugs as new treatments
Researchers have created a new open-access database of information on drug candidates and how they are metabolized by the body, which could help speed up the repurposing of old drugs as new treatments. There...
Brain’s Leptin Perception is Pivotal in Type 2 Diabetes, Study Reveals
When it comes to type 2 diabetes, we tend to think we know all there is to know and are resigned to lifelong insulin injections. But its causes are not uniform throughout the world....
Gamida Cell to Present at the BTIG Virtual Biotechnology Conference – Business Wire
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will participate in a fireside chat at the...
